Cadent Health and UCB are presenting a real-world case study at Fierce Pharma Week to explore where traditional ID-based signals fall short and how combining claims data with predictive signals can help close the gap in the patient journey for pharma marketers.

Public source

Publisher name

Public post

Traditional ID-based signals can leave critical blind spots in the patient journey for pharma marketers—especially when it comes to patients who have yet to be diagnosed…

Log in to read the full post

Company

Cadent

Industry
Advertising Services
Location
New York, US
Company size
501–1,000 employees

About Cadent

Cadent ignites seamless connections between brands, publishers & consumers. Our predictive AI orchestrates outcomes on any platform customers are on, across any media they consume & at any stage of the journey. To learn more, please visit Cadent.com.

See more

Latest activity

8 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.